NCT06847009 is a NA clinical trial of Acupressure application in Hemodialysis Treatment, sponsored by Didem Lafci.

Who is sponsoring NCT06847009?

NCT06847009 is sponsored by Didem Lafci.

What drugs are being tested in NCT06847009?

Interventions in NCT06847009: Acupressure application.

What condition does NCT06847009 study?

NCT06847009 studies Hemodialysis Treatment, Acupressure, Sleep.

Is NCT06847009 still recruiting?

NCT06847009 is currently not yet recruiting. Last updated 26 February 2025.

Last reviewed 2025-02-26 · How we verify

NCT06847009

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Acupressure on Sleep Quality in Hemodialysis Patients: a Randomized Controlled Trial

Not yet recruiting NA Last updated 26 February 2025

What this trial tests

NA trial testing Acupressure application in Hemodialysis Treatment in 60 participants. Not yet recruiting.

Timeline

15 May 2025

Primary endpoint
15 May 2025

30 September 2025

Quick facts

Lead sponsor	Didem Lafci
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	15 May 2025
Primary completion	15 May 2025
Estimated completion	30 September 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Acupressure application

Conditions studied

Hemodialysis Treatment — all drugs for Hemodialysis Treatment →
Acupressure — all drugs for Acupressure →
Sleep — all drugs for Sleep →

Sponsor

Didem Lafci

Who can join

Adults 18 to 65, any sex, with Hemodialysis Treatment or Acupressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the effects of acupressure applied to patients receiving hemodialysis treatment on sleep quality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06847009 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Didem Lafci
Last refreshed: 26 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06847009.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing